Lobectomy has always been considered the gold standard surgical procedure for non-small cell lung cancer (NSCLC), even for the treatment of early stage tumors, while the indication for sublobar resection has usually been limited to elderly patients or to those with impaired cardiac and respiratory function.
Should lobectomy still be considered the treatment of choice for stage IA non-small cell lung cancer? / Argento, Giacomo; Rendina, Erino Angelo; Maurizi, Giulio. - In: SHANGHAI CHEST. - ISSN 2521-3768. - (2023), pp. 1-3. [10.21037/SHC-22-60]
Should lobectomy still be considered the treatment of choice for stage IA non-small cell lung cancer?
Argento Giacomo;Rendina Erino Angelo;Maurizi Giulio
2023
Abstract
Lobectomy has always been considered the gold standard surgical procedure for non-small cell lung cancer (NSCLC), even for the treatment of early stage tumors, while the indication for sublobar resection has usually been limited to elderly patients or to those with impaired cardiac and respiratory function.File allegati a questo prodotto
| File | Dimensione | Formato | |
|---|---|---|---|
|
Argento_Should-lobectomy-still-be-considered_2023.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
121.15 kB
Formato
Adobe PDF
|
121.15 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
